The FDA expanded its approval for CAR-T therapy in treating cancer patients with relapsed or refractory follicular lymphoma after two or more lines of systemic therapy.
The Latest
The UC Davis Comprehensive Cancer Center named Xiao-Jing Wang, MD, PhD, its new chief scientific officer, the center said in a May 26 email to Becker's.
Cleveland-based University Hospitals Seidman Cancer Center appointed Koen van Besien, MD, PhD, to lead its division of hematology and as director of the Wesley Center for Immunotherapy on May 25.
Edgewood, Ky.-based St. Elizabeth Healthcare broke ground on its new three-story, 66,000-square-foot cancer facility May 13.
Philadelphia-based Penn Medicine and Children's Hospital of Philadelphia are partnering with Costa Rica's Caja Costarricense de Seguro Social (Social Security Program), to facilitate CAR-T research in Costa Rica.
Sarasota (Fla.) Memorial Hospital's new $220 million cancer pavilion was approved by the county's public hospital board, The Sarasota Herald-Tribune reported May 23.
Seven oncologists joined new practices or received new appointments in the last few weeks.
Pittsburgh-based UPMC Hillman Cancer Center opened its first location in Sicily at UPMC-managed ISMETT, a "leading transplant and high-specialty" hospital in Palermo.
Madison, Wis.-based UW Health, the integrated health system of the University of Wisconsin-Madison, is beginning construction on the first center in the world to offer upright proton beam cancer therapy, it said in an email to Becker's on May 17.
Cleveland Clinic Cancer Center has initiated a drug repository program providing orally administered drugs used in cancer treatment at no charge to eligible patients.